SUBSCRIBE
SUBSCRIBE
News   Drug Development

AstraZeneca PLC Drug Recommended in EU for Some Depression

April 23, 2010 | 
1 min read
Reuters -- AstraZeneca's (AZN.L) schizophrenia drug Seroquel XR has been recommended by European regulators as an add-on treatment for depression, following an earlier rebuff in the Netherlands.
Clinical research Postmarket research Regulatory Europe
AstraZeneca Pharmaceuticals LP
MORE ON THIS TOPIC
halftone magazine style banner, dislike, negative rating, hand thumbs down
FDA
FDA Drops Another Cache of Heavily Redacted Rejection Letters, Promises Future ‘Real-Time’ Access
September 4, 2025
 · 
4 min read
 · 
Annalee Armstrong
IN PARTNERSHIP WITH TACONIC BIOSCIENCES
The ‘Research Safety Net’ Saving Scientists from Funding Crisis
September 4, 2025
 · 
1 min read
 · 
Lori Ellis
Washington, D.C., USA- January 13, 2020: FDA Sign at its headquarters in Washington DC. The Food and Drug Administration (FDA or USFDA) is a federal agency of the USA.
Regulatory
‘All Wrapper, No Gift’: FDA Releases New Rare Disease Approval Framework
September 4, 2025
 · 
2 min read
 · 
Tristan Manalac
Vaccines
Prasad Demands YouTube Remove Videos Where He Criticized COVID-19 Vaccines
September 4, 2025
 · 
2 min read
 · 
Tristan Manalac